Back to Journals » Therapeutics and Clinical Risk Management » Volume 17 » default

Therapeutics and Clinical Risk Management


Archive: Volume 17, 2021

Cost-Effectiveness of Ferrous Fumarate–Folic Acid and Ferrous Gluconate–Multivitamins in a High Prevalence Area of Iron Deficiency Anemia in Indonesia

Rakanita Y, Syamsunarno MRAA, Sinuraya RK, Suradji EW, Abdulah R, Suwantika AA

Therapeutics and Clinical Risk Management 2021, 17:1075-1081

Published Date: 1 October 2021

Associations of LRP5 and MTHFR Gene Variants with Osteoarthritis Prevalence in Elderly Women: A Japanese Cohort Survey Randomly Sampled from a Basic Resident Registry

Nakano M, Yui H, Kikugawa S, Tokida R, Sakai N, Kondo N, Endo N, Haro H, Shimodaira H, Suzuki T, Kato H, Takahashi J, Nakamura Y

Therapeutics and Clinical Risk Management 2021, 17:1065-1073

Published Date: 29 September 2021

Novel Clinically Weight-Optimized Dynamic Conformal Arcs (WO-DCA) for Liver SBRT: A Comparison with Volumetric Modulated Arc Therapy (VMAT)

Saglam Y, Bolukbasi Y, Atasoy AI, Karakose F, Budak M, Alpan V, Topkan E, Selek U

Therapeutics and Clinical Risk Management 2021, 17:1053-1064

Published Date: 28 September 2021

Doxycycline in the Coronavirus Disease 2019 Therapy

Dorobisz K, Dorobisz T, Janczak D, Zatoński T

Therapeutics and Clinical Risk Management 2021, 17:1023-1026

Published Date: 21 September 2021

The Influence of COVID-19 Lockdown in Jordan on Patients with Diabetic Retinopathy: A Case–Control Study

Al-Dwairi RA, Rwashdeh H, Otoom M

Therapeutics and Clinical Risk Management 2021, 17:1011-1022

Published Date: 14 September 2021

Evaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor

Alshari O, Al Zu’bi YO, Al Sharie AH, Wafai FH, Aleshawi AJ, Atawneh FH, Obeidat HA, Daoud MN, Khrais MZ, Albals D, Tubaishat F

Therapeutics and Clinical Risk Management 2021, 17:963-973

Published Date: 7 September 2021

The Relationship of Drug Therapy to Aplastic Anemia in Pakistan: A Hospital-Based Case Control Study

Syed MA, Atta Ur Rahman A, Syed MNS, Memon NM

Therapeutics and Clinical Risk Management 2021, 17:903-908

Published Date: 27 August 2021

Identification of Hub Gene TIMP1 and Relative ceRNAs Regulatory Network in Colorectal Cancer

Qin YF, Li GM, Wang G, Kong DJ, Wang HD, Zhao YM, Hao JP, Qin H, Sun DQ, Wang H

Therapeutics and Clinical Risk Management 2021, 17:889-901

Published Date: 27 August 2021

The Correlation Between Low Serum T3 Levels and All-Cause and Cardiovascular Mortality in Peritoneal Dialysis Patients

Xu LC, Zhou FF, Li M, Dai ZW, Cai KD, Zhu BX, Luo Q

Therapeutics and Clinical Risk Management 2021, 17:851-861

Published Date: 19 August 2021

The Role of Dapagliflozin in the Management of Heart Failure: An Update on the Emerging Evidence

Gupta M, Rao S, Manek G, Fonarow GC, Ghosh RK

Therapeutics and Clinical Risk Management 2021, 17:823-830

Published Date: 12 August 2021

Analysis of Bleeding Site to Identify Associated Risk Factors of Intractable Epistaxis

Liao Z, Guo J, Mi J, Liao W, Chen S, Huang Y, Xu Y, Zhang J, Yang Q, Hong H

Therapeutics and Clinical Risk Management 2021, 17:817-822

Published Date: 12 August 2021

Short- to Mid-Term Clinical Outcomes of Posterior-Stabilized Cementless Total Knee Arthroplasty with Trabecular Metal Components

Momose T, Nakamura Y, Nakano M, Maeda T, Morioka S, Sobajima A, Nakatsuchi Y, Takahashi J, Nawata M

Therapeutics and Clinical Risk Management 2021, 17:809-816

Published Date: 10 August 2021

Risk Factors of Mechanical Ventilation in Premature Infants During Hospitalization

Yue G, Wang J, Li H, Li B, Ju R

Therapeutics and Clinical Risk Management 2021, 17:777-787

Published Date: 30 July 2021

Assessing the Safety and Efficacy of Trifarotene in the Treatment of Acne Vulgaris

Brumfiel CM, Patel MH, Bell KA, Cardis MA

Therapeutics and Clinical Risk Management 2021, 17:755-763

Published Date: 26 July 2021

Happiness: A Novel Outcome Measure in Stroke?

Wijeratne T, Sales C, Wijeratne C, Jakovljevic M

Therapeutics and Clinical Risk Management 2021, 17:747-754

Published Date: 27 July 2021

Optimal Use of Perampanel in Asian Patients with Epilepsy: Expert Opinion

Chinvarun Y, Huang CW, Wu Y, Lee HF, Likasitwattanakul S, Ding J, Yamamoto T

Therapeutics and Clinical Risk Management 2021, 17:739-746

Published Date: 21 July 2021

Serum Hypoxia-Inducible Factor 1alpha Levels Correlate with Outcomes After Intracerebral Hemorrhage

Cai Y, Zhuang YK, Wu XY, Dong XQ, Du Q, Yu WH, Wang KY, Hu W, Zheng YK

Therapeutics and Clinical Risk Management 2021, 17:717-726

Published Date: 13 July 2021

Clopidogrel-Induced Interstitial Lung Disease: A Case Report

An J, Lee SH, Chang B

Therapeutics and Clinical Risk Management 2021, 17:711-715

Published Date: 12 July 2021

Update on Diagnosis and Treatment of Adult Pulmonary Alveolar Proteinosis

Iftikhar H, Nair GB, Kumar A

Therapeutics and Clinical Risk Management 2021, 17:701-710

Published Date: 10 August 2021

Correlation Between Calcification Characteristics of Carotid Atherosclerotic Plaque and Plaque Vulnerability

Xu X, Hua Y, Liu B, Zhou F, Wang L, Hou W

Therapeutics and Clinical Risk Management 2021, 17:679-690

Published Date: 1 July 2021

Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach

Grimaud F, Penaranda G, Stavris C, Retornaz F, Brunel V, Cailleres S, Pegliasco H, Le Treut J, Grisoni V, Coquet E, Chiche L, Rognon A

Therapeutics and Clinical Risk Management 2021, 17:669-677

Published Date: 30 June 2021

Therapeutic Agents Rounding Up the Immunopathology of COVID-19

Li HP, He X, Zhang L, Li CX, Li SQ, Li QY

Therapeutics and Clinical Risk Management 2021, 17:657-668

Published Date: 29 June 2021

Exploring the Effectiveness of PAC Rehabilitation for Elders with Hip Surgery: A Retrospective Study

Yang JL, Ou YH, Liu SY, Lin CH, Chang SW, Lu YH, Shen T, Hsieh CP, Lin CM, Lei RL

Therapeutics and Clinical Risk Management 2021, 17:641-648

Published Date: 23 June 2021

Arterial Embolism in Malignancy: The Role of Surgery

Harnarayan P, Islam S, Naraynsingh V

Therapeutics and Clinical Risk Management 2021, 17:635-640

Published Date: 18 June 2021

Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid Leukemia

Perrone V, Giacomini E, Andretta M, Arenare L, Cillo MR, Latini M, Mecozzi A, Pagliaro R, Vercellone A, Degli Esposti L

Therapeutics and Clinical Risk Management 2021, 17:617-622

Published Date: 8 June 2021

Gene Therapy for Overactive Bladder: A Review of BK-Channel α-Subunit Gene Transfer

Andersson KE, Christ GJ, Davies KP, Rovner ES, Melman A

Therapeutics and Clinical Risk Management 2021, 17:589-599

Published Date: 4 June 2021

IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy

Taoka M, Ochi N, Mimura A, Ichiyama N, Nagasaki Y, Nakagawa N, Nakanishi H, Yamane H, Oshiro Y, Monobe Y, Takigawa N

Therapeutics and Clinical Risk Management 2021, 17:571-575

Published Date: 3 June 2021

The Diagnostic Value of Plasma miRNA-497, cTnI, FABP3 and GPBB in Pediatric Sepsis Complicated with Myocardial Injury

Huang C, Xiao S, Xia Z, Cheng Y, Li Y, Tang W, Shi B, Qin C, Xu H

Therapeutics and Clinical Risk Management 2021, 17:563-570

Published Date: 1 June 2021

Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease

Tu C, Wang G, Geng Y, Guo N, Cui N, Liu J

Therapeutics and Clinical Risk Management 2021, 17:553-561

Published Date: 1 June 2021

Non-Surgical Treatment of Knee Osteoarthritis: Multidisciplinary Italian Consensus on Best Practice

Pradelli L, Sinigaglia T, Migliore A, Checchia GA, Franceschi F, Frediani B, Iannone F, Romanini E

Therapeutics and Clinical Risk Management 2021, 17:507-530

Published Date: 28 May 2021

Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis

Sommer I, Palmero D, Fischer Fumeaux CJ, Bonnabry P, Bouchoud L, Sadeghipour F

Therapeutics and Clinical Risk Management 2021, 17:497-506

Published Date: 28 May 2021

Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus

Ichikawa C, Tanaka S, Takubo M, Kushimoto M, Ikeda J, Ogawa K, Tsujino I, Suzuki Y, Abe M, Ishihara H, Fujishiro M

Therapeutics and Clinical Risk Management 2021, 17:463-470

Published Date: 25 May 2021

Risk Factors for Cerebral Infarction After Moderate or Severe Traumatic Brain Injury

Wu Y, Chao Y, Gao G, Bao D, Dong Y, Wei X, Niu C

Therapeutics and Clinical Risk Management 2021, 17:433-440

Published Date: 21 May 2021

The Value of Chinese Version GAD-7 and PHQ-9 to Screen Anxiety and Depression in Chinese Outpatients with Atypical Chest Pain

Lin Q, Bonkano O, Wu K, Liu Q, Ali Ibrahim T, Liu L

Therapeutics and Clinical Risk Management 2021, 17:423-431

Published Date: 18 May 2021

Myocardial Injury After Temporary Transvenous Cardiac Pacing

Liu M, Wu P

Therapeutics and Clinical Risk Management 2021, 17:415-421

Published Date: 18 May 2021

Changes in Distribution of Lower Limb Alignment After Total Hip Arthroplasty for Crowe IV Developmental Dysplasia of the Hip

Sun J, Guo L, Ni M, Shen J, Du Y, Zhang B, Zhang G, Zhou Y

Therapeutics and Clinical Risk Management 2021, 17:389-396

Published Date: 3 May 2021

Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review

Saghir SAM, AlGabri NA, Alagawany MM, Attia YA, Alyileili SR, Elnesr SS, Shafi ME, Al-shargi OYA, Al-balagi N, Alwajeeh AS, Alsalahi OS, Patra AK, Khafaga AF, Negida A, Noreldin A, Al-Amarat W, Almaiman AA, El-Tarabily KA, Abd El-Hack ME

Therapeutics and Clinical Risk Management 2021, 17:371-387

Published Date: 28 April 2021

Risk Perception of Septic Shock with Multiple Organ Failure Due to Acute Exacerbation of an Infectious Dental Disease

Sato H, Tamanoi T, Suzuki T, Moriyama H, Abe S, Yoshida K, Kawaai H, Yamazaki S

Therapeutics and Clinical Risk Management 2021, 17:365-369

Published Date: 22 April 2021

Risk Factors for Tigecycline-Associated Hypofibrinogenemia

Liu J, Yan Y, Zhang F

Therapeutics and Clinical Risk Management 2021, 17:325-332

Published Date: 16 April 2021

Dietary and Lifestyle Factors Related to Gastroesophageal Reflux Disease: A Systematic Review

Zhang M, Hou ZK, Huang ZB, Chen XL, Liu FB

Therapeutics and Clinical Risk Management 2021, 17:305-323

Published Date: 15 April 2021

Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety

Maconi G, Camatta D, Cannatelli R, Ferretti F, Carvalhas Gabrielli A, Ardizzone S

Therapeutics and Clinical Risk Management 2021, 17:285-292

Published Date: 7 April 2021

Heart Rate Predicts the Risk of New-Onset Peripheral Arterial Disease in a Community-Based Population in China

Gao Y, Fan F, Jia J, Jiang Y, He D, Wu Z, Huo Y, Zhou J, Zhang Y

Therapeutics and Clinical Risk Management 2021, 17:267-274

Published Date: 26 March 2021

Neutrophil/Lymphocyte Ratio as an Inflammatory Predictor of Dry Eye Disease: A Case-Control Study

Meng YF, Pu Q, Ma Q, Zhu W, Li XY

Therapeutics and Clinical Risk Management 2021, 17:259-266

Published Date: 23 March 2021

Left Ventricular Remodeling Risk Predicted by Two-Dimensional Speckle Tracking Echocardiography in Acute Myocardial Infarction Patients with Midrange or Preserved Ejection Fraction in Western Romania

Bordejevic DA, Pârvănescu T, Petrescu L, Mornoș C, Olariu I, Crișan S, Văcărescu C, Lazăr M, Morariu VI, Citu IM, Tomescu MC, Cozma D

Therapeutics and Clinical Risk Management 2021, 17:249-258

Published Date: 23 March 2021

Effects of Impacted Lower Third Molar Extraction on Periodontal Tissue of the Adjacent Second Molar

Zhang Y, Chen X, Zhou Z, Hao Y, Li H, Cheng Y, Ren X, Wang X

Therapeutics and Clinical Risk Management 2021, 17:235-247

Published Date: 22 March 2021

Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges [Corrigendum]

Dubin C, Del Duca E, Guttman-Yassky E

Therapeutics and Clinical Risk Management 2021, 17:233-234

Published Date: 18 March 2021

Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization

Simonetti O, Rizzetto G, Molinelli E, Cirioni O, Offidani A

Therapeutics and Clinical Risk Management 2021, 17:223-232

Published Date: 22 March 2021

Polycythemia Vera (PV): Update on Emerging Treatment Options

Benevolo G, Vassallo F, Urbino I, Giai V

Therapeutics and Clinical Risk Management 2021, 17:209-221

Published Date: 16 March 2021

Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma

Jezeršek Novaković B, Boltežar L, Novaković A

Therapeutics and Clinical Risk Management 2021, 17:183-192

Published Date: 2 March 2021

Potentially Inappropriate Prescriptions to Older Patients in Emergency Departments in South Korea: A Retrospective Study

Kim K, Jung J, Kim H, Kim JT, Oh JM, Kim H

Therapeutics and Clinical Risk Management 2021, 17:173-181

Published Date: 19 February 2021

The Prevalence and Risk Factors of Cerebral Microbleeds: A Community-Based Study in China

Luo Q, Tang H, Xu X, Huang J, Wang P, He G, Song X, Huang Y, Chen S, Yan F, Tan Y, Ma J

Therapeutics and Clinical Risk Management 2021, 17:165-171

Published Date: 18 February 2021

Development of a Risk Scoring System for Predicting Anastomotic Leakage Following Laparoscopic Rectal Cancer Surgery

Han Z, Chen D, Li Y, Zhou G, Wang M, Zhang C

Therapeutics and Clinical Risk Management 2021, 17:145-153

Published Date: 17 February 2021

Lung Function Assessment by Impulse Oscillometry in Adults [Corrigendum]

Porojan-Suppini N, Fira-Mladinescu O, Marc M, Tudorache E, Oancea C

Therapeutics and Clinical Risk Management 2021, 17:135-136

Published Date: 2 February 2021

Combination of Multiple Hemodialysis Modes: Better Treatment Options for Patients Under Maintenance Hemodialysis

Zhang ZY, Li MX, Yu H, Zhao J, Xiao FL, Xuan F, Zhao YX

Therapeutics and Clinical Risk Management 2021, 17:127-133

Published Date: 29 January 2021

Clinical Features of Segmental Infantile Hemangioma: A Prospective Study

Qiu T, Yang K, Dai S, Chen S, Ji Y

Therapeutics and Clinical Risk Management 2021, 17:119-125

Published Date: 27 January 2021

Long-Term Follow-Up and Clinical Relevance of Incidental Findings of Fibrin Sheath and Thrombosis on Computed Tomography Scans of Cancer Patients with Port Catheters

Lichtenstein T, Mammadov K, Rau K, Große Hokamp N, Do TD, Maintz D, Chang DH

Therapeutics and Clinical Risk Management 2021, 17:111-118

Published Date: 27 January 2021

Effects of Scleral Contact Lenses for Keratoconus Management on Visual Quality and Intraocular Pressure

Formisano M, Franzone F, Alisi L, Pistella S, Spadea L

Therapeutics and Clinical Risk Management 2021, 17:79-85

Published Date: 25 January 2021

Growth Promoting Effect of Vacuum Sealing Drainage in the Healing Processes of Diabetic Foot Ulcers

Yang H, Liu L, Li G, Chen Y, Jiang D, Wang W, Wang T, Sun J, Che J, Gu D, Lu M, Wang A

Therapeutics and Clinical Risk Management 2021, 17:65-71

Published Date: 19 January 2021

Emerging B-Cell Therapies in Systemic Lupus Erythematosus

Bag-Ozbek A, Hui-Yuen JS

Therapeutics and Clinical Risk Management 2021, 17:39-54

Published Date: 14 January 2021

Clinical Features for Severely and Critically Ill Patients with COVID-19 in Shandong: A Retrospective Cohort Study

Zhou S, Xu J, Sun W, Zhang J, Zhang F, Zhao X, Wang X, Zhang W, Li Y, Ning K, Pan Y, Liu T, Zhao J, Yu J, Sun Y, Gao F, Zhang R, Fu C, Sun Y, Ouyang X, Zhang F, Hu Q, Teng H, Li Y, Zhang C, Tan W, Li J, Yin L, Dong L, Wang C

Therapeutics and Clinical Risk Management 2021, 17:9-21

Published Date: 6 January 2021